Frequently Asked Questions About MYCO.NE

What does Mydecine Innovations Group Inc. do?

Mydecine Innovations Group Inc. (MYCO.NE) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is MYCO.NE's market cap?

Mydecine Innovations Group Inc. (MYCO.NE) has a market capitalization of approximately $21.4 million, as of January 13, 2026, based on the most recent share price and shares outstanding.

Does MYCO.NE pay a dividend?

No — Mydecine Innovations Group Inc. (MYCO.NE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is MYCO.NE profitable?

Mydecine Innovations Group Inc. (MYCO.NE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

MYCO.NE (Mydecine Innovations Group Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

MYCO.NE

Mydecine Innovations Group Inc.

NEO·Drug Manufacturers, Specialty & Generic · Healthcare

C$0.35C$0.00+0.00%

Market capC$21.42M·Market closed·Jan 13 5:03 PM UTC

Price Chart

C$0.35+C$0.00 (+0.00%)today

−98.46%CAGR −56.65%

Select date range

FromTo

Sep 15, 2014Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

MYCO.NE does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 27

Last Report DateJul 22

Reported vs Estimate−C$0.00

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net IncomeC$220.73K

Net Margin—

Operating Cash Flow−C$13.37K

Capital ExpendituresC$0.00

Free Cash Flow−C$13.37K

Return on Equity—

Return on Invested Capital2.9%

Net DebtC$7.03M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for MYCO.NE and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how MYCO.NE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MYCO.NE and 80,000+ other tickers.

About Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc. is a biotechnology and life sciences enterprise dedicated to advancing and commercializing therapies for a range of mental health conditions. The company specializes in developing treatments for specific populations, including veterans, emergency medical service providers, frontline workers, and individuals affected by post-traumatic stress disorder. It also operates Mindleap, an online telehealth platform offering mental wellness services and support for psychedelic integration, including aftercare. Furthermore, Mydecine engages in drug discovery, developing…

CEO: David Joshua Bartch
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: NEO
Employees: 3
Website: www.mydecine.com

Peers

CLS Holdings USA, Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About MYCO.NE

What does Mydecine Innovations Group Inc. do?: Mydecine Innovations Group Inc. (MYCO.NE) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is MYCO.NE's market cap?: Mydecine Innovations Group Inc. (MYCO.NE) has a market capitalization of approximately $21.4 million, as of January 13, 2026, based on the most recent share price and shares outstanding.
Does MYCO.NE pay a dividend?: No — Mydecine Innovations Group Inc. (MYCO.NE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is MYCO.NE profitable?: Mydecine Innovations Group Inc. (MYCO.NE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.